SlidesetHIVInternational Workshop on HIV Pediatrics 2021Virological Failures and Genotypic Resistance in Children and Adolescents Randomised to Dolutegravir-Based ART vs. Standard-of- Care in the ODYSSEY Trial - Cissy Kityo, UgandaView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2021Longitudinal Study on Insulin Resistance and Metabolic Syndrome in Children with Perinatal HIV Infection and HIV Exposed Uninfected Children in South Africa - Claire Davies, South AfricaView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2021Weight Gain in Children and Adolescents on Dolutegravir vs Standard-of-Care in the ODYSSEY Trial - Hilda Angela Mujuru, ZimbabweView Slideset
MvdZMarieke van der ZalmMD, MSc (Clin Epi), PhDSlidesetHIVInternational Workshop on HIV Pediatrics 2021Pro (Children Should Be Prioritized) - Marieke van der Zalm, MD, MSc (Clin Epi), PhDView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2021LATE BREAKER - Dolutegravir-Based Art is Superior to Standard of Care in Young Children Living With HIV - Pauline Amuge, UgandaView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2021Clinical Impact and Cost-Effectiveness of Viral Load Testing (VLT) to Inform the Transition to Pediatric Dolutegravir (DTG) in Antiretroviral Therapy (ART)-Experienced Children With HIV in South Africa - Isaac Ravi Brenner, United StatesView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2021Pharmacokinetics and Safety of Dispersible- and Immediate-Release FDC Dolutegravir/Abacavir/Lamivudine in Children with HIV Weighing ≥14 Kg: Preliminary Results from IMPAACT 2019 - Kristina Brooks, United StatesView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2021B/F/Taf in Virologically Suppressed Adolescents and Children: Two- Year Outcomes in 6 to <18 Year Olds And Six-Month Outcomes in Toddlers - Eva Natukunda, UgandaView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2021Once-Daily Integrase Inhibitor (Insti) With Boosted Darunavir is Non- Inferior to Standard of Care in Virogically Suppressed Children, Week 48 Results of the Smile PENTA-17 Trial - Alexandra Compagnucci, FranceView Slideset
PEPeter ElyanuMBChB, MMed, PhDSlidesetHIVInternational Workshop on HIV Pediatrics 2021Progress – and Lack of Progress - on DTG Transition in Children in Africa - Peter Elyanu, MBChB, M.Med, PhDView Slideset
SMShabir MadhiMBBCh, FCPaeds, PhDSlidesetHIVInternational Workshop on HIV Pediatrics 2021Situation Report: African COVID-19 Pandemic in Children - Shabir Madhi, MBBCh, FCPaeds, PhDView Slideset
SLShahin LockmanMD, MScSlidesetHIVInternational Workshop on HIV Pediatrics 2021Approaches to Enhance and Accelerate Study of New Drugs for HIV and Coinfections in Pregnancy - Shahin Lockman, MD, MScView Slideset
